Evidence map›Paper›PMID 22430799›Full record

ArticleEpigenetics2012

Neonatal MeCP2 is important for the organization of sex differences in vasopressin expression.

Robin M Forbes-Lorman, Jared J Rautio, Joseph R Kurian, Anthony P Auger, Catherine J Auger

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Epigenetic Modulation of Vasopressin Expression in Health and Disease.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Epigenetic impacts of endocrine disruptors in the brain.Frontiers in neuroendocrinology · 2017
    Review
  10. Article
  11. Article
  12. At the frontier of epigenetics of brain sex differences.Frontiers in behavioral neuroscience · 2015
    Review
  13. Review
  14. Sensitive periods for hormonal programming of the brain.Current topics in behavioral neurosciences · 2014
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Gender differences in neurodevelopment and epigenetics.Pflugers Archiv : European journal of physiology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Robin M Forbes-LormanPsychology Department, University of Wisconsin-Madison, Madison, WI, USA.
Jared J Rautio
Joseph R Kurian
Anthony P Auger
Catherine J Auger
Madison Group (United States) · USUniversity of Wisconsin–Madison · USInstitute of Psychology · RU

Funding

Steroid Receptors and Brain Sex DifferencesR01MH072956 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI AUGER, ANTHONY P · 2006 to 2010
$1.5M
NIMH NIH HHS R01 MH072956NIMH NIH HHS R01MH072956
6 · The paper itself

Abstract

Several neurodevelopmental disorders are marked by atypical Methyl-CpG-binding protein 2 (MeCP2) expression or function; however, the role of MeCP2 is complex and not entirely clear. Interestingly, there are sex differences in some of these disorders, and it appears that MeCP2 has sex-specific roles during development. Specifically, recent data indicate that a transient reduction in MeCP2 within developing amygdala reduces juvenile social play behavior in males to female-typical levels. These data suggest that MeCP2 within the amygdala is involved in programming lasting sex differences in social behavior. In the present study, we infused MeCP2 or control siRNA into the amygdala of male and female rats during the first three days of postnatal life in order to assess the impact of a transient reduction in MeCP2 on arginine vasopressin (AVP), a neural marker that is expressed differentially between males and females and is linked to a number of social behaviors. The expression of AVP, as well as several other genes, was measured in two-week old and adult animals. Two-week old males expressed more AVP and galanin mRNA in the amygdala than females, and a transient reduction in MeCP2 eliminated this sex difference by reducing the expression of both gene products in males. A transient reduction in MeCP2 also decreased androgen receptor (AR) mRNA in two-week old males. In adulthood, control males had more AVP-immunoreactive (AVP-ir) cells than females in the centromedial amygdala (CMA), bed nucleus of the stria terminalis (BST) and in the fibers that project from these cells to the lateral septum (LS). A transient reduction in MeCP2 eliminated this sex difference. Interestingly, there were no lasting differences in galanin or AR levels in adulthood. Reducing MeCP2 levels during development did not alter estrogen receptorα, neurofilament or Foxg1. We conclude that a transient reduction in MeCP2 expression in the developing male amygdala has a transient impact on galanin and AR expression but a lasting impact on AVP expression, highlighting the importance of MeCP2 in organizing sex differences in the amygdala.

Indexed as

Sex CharacteristicsAmygdalaAnimalsAnimals, NewbornArginine VasopressinBehavior, AnimalFemaleGalaninGene Expression RegulationGene SilencingMaleMethyl-CpG-Binding Protein 2RatsRats, Sprague-DawleyReceptors, AndrogenRNA, Small InterferingArginine VasopressinGalaninMethyl-CpG-Binding Protein 2Receptors, AndrogenRNA, Small Interfering

Identifiers

PMID22430799
PMCPMC3335947
OpenAlexW2085369703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.